Wytyczne postepowania w krwawieniu z górnego odcinka przewodu pokarmowego pochodzenia nieżlakowego

Przeglad Gastroenterologiczny

Volumn 3, Issue 1, 2008, Pages 1-22

  Marek, Tomasz ^a   Baniukiewicz, Andrzej ^b   Wallner, Grzegorz ^c   Rydzewska, Grazyna ^d   Dabrowski, Andrzej ^b  

^a Uniwersytetu Medycznego   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c AM   (Poland)

^d NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51449086668     PISSN: 18955770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (178)

1. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 2002; 51 (Suppl IV): iv1-iv6.
2. Barkun A, Bardou M, Marshall JK for the Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. Ann Intern Med 2003; 139: 843-57.
3. Lundell L GI haemorrhage - surgical aspects. EAGE 2nd European Postgraduate School in Gastroenterology. Abstracts 28-29.
4. The Standard of Practice Committeee of the ASGE (Adler DG, Leighton JA, Davila RE i wsp.). ASGE guideline: the role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004; 60: 497-504.
5. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311: 222-6.
6. Dulai GS, Gralnek IM, Oei TT i wsp. Utilization of health care resources for low-risk patients with acute, nonvariceal upper GI hemorrhage: an historical cohort study. Gastrointest Endosc 2002; 55: 321-7.
7. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998; 47: 219-22.
8. Cipolletta L, Bianco MA, Rotondano G i wsp. Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 2002; 55: 1-5.
9. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
10. Daneshmend TK, Hawkey CJ, Langman MJ i wsp. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992; 304: 143-7.
11. Andrews C, Levy A, Fishman M i wsp. Intravenous proton pump inhibitor (IV IPPs) prior to endoscopy "downstage" high-risk lesion in patients with bleeding peptic ulcer (PUD): a multicenter comparative study [Abstract]. Gastrointest Endosc 2003; 57: AB 149.
12. Lau JY, Leung WK, Wu JC i wsp. Omeprazole before endoscopy in patients with gastrointestinal bleeding. New Engl J Med 2007; 356: 1631-40.
13. Keyvani L, Murthy S, Leeson S, Targownik LE. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Aliment Pharmacol Ther 2006; 24: 1247-55.
14. Dorward S, Sreedharan A, Leontiadis GI i wsp. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in unselected upper gastrointestinal bleeding. Cochrane Database Syst Rev 2006; 4: CD005415.
15. Barkun A, Kennedy W, Herba K i wsp. The cost effectiveness of proton pump inhibitor continuous infusion (IV IPP) administered prior to endoscopy in the treatment of patients with non-variceal upper GI bleeding. The RUGBE Investigators [Abstract]. Gastroenterology 2002; 122: A67.
16. Enns RA, Gagnon YM, Rioux KP, Levy AR. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2003; 17: 225-33.
17. Frossard JL, Spahr L, Queneau PE i wsp. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double blind trial. Gastroenterology 2002; 123: 17-23.
18. Coffin B, Pocard M, Panis Y i wsp. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 2002; 56: 174-9.
19. Carbonell N, Pauwels A, Serfaty L i wsp. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol 2006; 101: 1211-5.
20. Lin HJ, Wang K, Perng CL i wsp. Early or delayed endoscopy for patients with peptic ulcer bleeding. A prospective randomized study. J Clin Gastroenterol 1996; 22: 267-71.
21. Cooper GS, Chak A, Connors AF Jr i wsp. The effectiveness of early endoscopy for upper gastrointestinal hemorrhage: a community-based analysis. Med Care 1998; 36: 462-74.
22. Cooper GS, Chak A, Way LE i wsp. Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay. Gastrointest Endosc 1999; 49: 145-52.
23. Lee JG, Turnipseed S, Romano PS i wsp. Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 1999; 50: 755-61.
24. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-7.
25. Wu JC, Sung JJ. Upper gastrointestinal bleeding diseases. W: Gastroenterological Endoscopy. Classen M, Tytgat GN, Lightdale CJ (red.). Thieme, Stuttgart 2002; 538-47.
26. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 717-27.
27. Therapeutic endoscopy and bleeding ulcers. Natl Inst Health Consens Dev Conf Consens Statement 1989; 7: 1-7.
28. Sacks HS, Chalmers TC, Blum AL i wsp. Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. JAMA 1990; 264: 494-9.
29. Cook DJ, Gayatt GH, Salena BJ i wsp. Endoscopic therapy for acute non-variceal haemorrhage: a meta-analysis. Gastroenterology 1992; 102: 139-48.
30. Jensen DM, Machicado GA. Endoscopic hemostasis of ulcer hemorrhage with injection, thermal, and combination methods. Tech Gastrointest Endosc 2005; 7: 124-31.
31. Hui AJ, Sung JJ. Endoscopic treatment of upper gastrointestinal bleeding. Curr Treat Options Gastroenterol 2005; 8: 153-62.
32. Bleau BL, Gostout CJ, Sherman KE i wsp. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002; 56: 1-6.
33. Jensen DM, Kovacs TO, Jutabha R i wsp. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002; 123: 407-13.
34. Kahi CJ, Jensen DM, Sung JJ i wsp. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology 2005; 129: 855-62.
35. Sung JJ, Chan FK, Lau JY i wsp. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003; 139: 237-43.
36. Laine L Systematic review of endoscopic therapy for ulcers with clots: can a meta-analysis be misleading? Gastroenterology 2005; 129: 2127.
37. Mondardini A, Barletti C, Rocca G i wsp. Non-variceal upper gastrointestinal bleeding and Forrest's classification: diagnostic agreement between endoscopists from the same area. Endoscopy 1998; 30: 508-12.
38. Bardou M, Youssef M, Toubouti Y i wsp. Newer endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: a series of meta-analyses [Abstract]. Gastroenterology 2003; 123: A239.
39. Chung SC, Leung JW, Steele RJ i wsp. Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial. Br Med J (Clin Res Ed) 1988; 296: 1631-3.
40. Lai KH, Peng SN, Guo WS i wsp. Endoscopic injection for the treatment of bleeding ulcers: local tamponade or drug effect? Endoscopy 1994; 26: 338-41.
41. Lau JY, Chung SC. Hemostasis: injection sclerotherapy, banding, mechanical methods, heater probe, and other methods. W: Gastroenterological Endoscopy. Classen M, Tytgat GN, Lightdale CJ (red.). Thieme, Stuttgart 2002; 262-73.
42. Park CH, Lee SJ, Park JH i wsp. Optimal injection volume of epinephrine for endoscopic prevention of recurrent peptic ulcer bleeding. Gastrointest Endosc 2004; 60: 875-80.
43. Liou TC, Lin SC, Wang HY, Chang WH. Optimal injection volume of epinephrine for endoscopic treatment of peptic ulcer bleeding. World J Gastroenterol 2006; 12: 3108-13.
44. Choudari CP, Palmer KR. Endoscopic injection therapy for bleeding peptic ulcer; a comparison of adrenaline alone with adrenaline plus ethanolamine oleate. Gut 1994; 35: 608-10.
45. Chung SC, Lau JY, Sung JJ i wsp. Randomized comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. Br Med J 1997; 314: 1307-11.
46. Vergara M, Calvet X, Gisbert JP. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. Cochrane Database Syst Rev 2007; 2: CD005584.
47. Chung SC, Leung JW, Leong HT i wsp. Adding a sclerosant to endoscopic epinphrine injection in actively bleeding ulcers: randomised trial. Gastrointest Endosc 1993; 39: 611-5.
48. Chung SC, Leong HT, Chan AC i wsp. Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial. Gastrointest Endosc 1996; 43: 591-5.
49. Lazo MD, Andrade R, Medina MC i wsp. Effect of injection sclerosis with alcohol on the rebleeding rate of gastroduodenal ulcers with unbleeding visible vessels; a prospective controlled trial. Am J Gastroneterol 1992; 87: 843-6.
50. Rutgeerts P, Rauws E, Wara P i wsp. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet 1997; 350: 692-6.
51. Jensen DM, Machicado GA. Principles, technical guidelines, and results of arterial hemostasis with coagulation probes. W: Gastroenterological Endoscopy. Classen M, Tytgat GN, Lightdale CJ (red.). Thieme, Stuttgart 2002; 274-83.
52. Laine L Multipolar electroagulaction in the treatment of peptic ulcer with nonbleeding visible vesels: a prospective, controlled trial. Ann Int Med 1989; 110: 510-4.
53. Swain CP, Mills TN, Shemesh E i wsp. Which electrode? A comparison of four endoscopic methods of electrocoagulation in experimental bleeding ulcers. Gut 1984; 25: 1424-31.
54. Costamagna G. Argon plasma coagulation. W: Gastroenterological Endoscopy. Classen M, Tytgat GN, Lightdale CJ (red.). Thieme, Stuttgart 2002; 290-301.
55. Ginsberg GG, Barkun AN, Bosco JJ i wsp. The argon plasma coagulator: February 2002. Gastrointest Endosc 2002; 55: 807-10.
56. Cipolletta L, Bianco MA, Rotondano G i wsp. Prospective comparison of argon plasma coagulator and heater probe in the endoscopic treatment of major peptic ulcer bleeding. Gastrointest Endosc 1998; 48: 191-5.
57. Watson JP, Bennett MK, Griffin SM i wsp. The tissue effect of argon plasma coagulation on esophageal and gastric mucosa. Gastrointest Endosc 2000; 52: 342-5.
58. Sung JJ, Tsoi KK, Lai LH i wsp. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 2007; 56: 1364-73.
59. Marmo R, Rotondano G, Piscopo R i wsp. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007; 102: 279-89.
60. Chau CH, Siu WT, Law BK i wsp. Randomized controlled trial comparing epinephrine injection plus heat probe coagulation versus epinephrine injection plus argon plasma coagulation for bleeding peptic ulcers. Gastrointest Endosc 2003; 57: 455-61.
61. Skok P, Ceranic D, Sinkovic A, Pocajt M. Peptic ulcer hemorrhage: Argon plasma coagulation versus injection sclerotherapy: a prospective, randomised. Verdauungskrankheiten 2001; 9: 107-13.
62. Havanond C, Havanond P. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleeding. Cochrane Database Syst Rev 2005; 2: CD003791.
63. Wong RM, Ota S, Katoh A i wsp. Endoscopic ligation for non-esophageal variceal upper gastrointestinal hemorrhage. Endoscopy 1998; 30: 774-7.
64. Chung MG, Kim YK, Kim HM i wsp. Is endoscopic band ligation more effective than electrocoagulation in the treatment of bleeding Dieulafoy's lesion? [Abstract]. Gastrointest Endosc 2005; 61: AB162.
65. Park CH, Lee WS, Joo YE i wsp. Endoscopic band ligation for control of acute peptic ulcer bleeding. Endoscopy 2004; 36: 79-82.
66. Raju GS, Gajula L Endoclips for GI endoscopy. Gastrointest Endosc 2004; 59: 267-79.
67. Yeh RW, Kaltenbach T, Soetikno R. Endoclips. Tech Gastrointest Endosc 2006; 8: 2-11.
68. Kaltenbach T, Friedland S, Barro J, Soetikno R. Clipping for upper gastrointestinal bleeding. Am J Gastroenterol 2006; 101: 915-8.
69. Sung JJ, Tsoi KK, Lau JY. Hemoclips versus thermoagulation for the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis [Abstract]. Gastrointest Endosc 2006; 65: AB121.
70. Cipolletta L, Rotondano G, Bianco MA i wsp. Mechanical modalities of endoscopic therapy: clips, loops and beyond. Tech Gastroinest Endosc 2005; 7: 132-8.
71. Chung IK, Ham JS, Him HS i wsp. Comparison of the haemostatic efficacy of the endoscopic haemoclip method with hypertronic saline epinephrine injection and a combination of the two for the management of bleeding peptic ulcer. Gastrointest Endosc 1999; 49: 13-8.
72. Sung JJ, Tsoi KK, Lau JY. Hemoclips versus endoscopic injection for the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis [Abstract]. Gastrointest Endosc 2007; 65: AB187.
73. Vergara M, Calvet X, Brullet E i wsp. Adding a second hemostatic procedure after epinephrine injection reduces rebleeding, surgery, and mortality in bleeding peptic ulcer patients: a meta-analysis [Abstract]. Gastrointest Endosc 2003; 57: AB 118.
74. Calvet X, Vergara M, Brullet E i wsp. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology 2004; 126: 441-50.
75. Bardou M, Martel M, Toubouti Y i wsp. Combination of hemoclipping and epinephrine injection decrease re-bleeding and surgery in high-risk patients with acute peptic ulcer bleeding: a meta-analysis [Abstract]. Gastrointest Endosc 2006; 65: AB169.
76. Marmo R, Rotondano G, Falasco G i wsp. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis [Abstract]. Gastrointest Endosc 2005; 61: AB91.
77. Villanueva C, Balanzó J, Espinós JC i wsp. Prediction of therapeutic failure in patients with bleeding peptic ulcer treated with endoscopic injection. Dig Dis Sci 1993; 38: 2062-70.
78. Brullet E, Calvet X, Campo R i wsp. Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996; 43: 111-6.
79. Brullet E, Campo R, Calvet X i wsp. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996; 39: 155-8.
80. Wong SK, Yu LM, Lau JY i wsp. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002; 50: 322-5.
81. Thomopoulos KC, Theocharis GJ, Vagenas KA i wsp. Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel. Scand J Gastroenterol 2004; 39: 600-4.
82. Bharucha AE, Gostout CJ, Balm RK. Clinical and endoscopic risk factors in the Mallory-Weiss syndrome. Am J Gastroenterol 1997; 92: 805-8.
83. Morales P, Baum AE. Therapeutic alternatives for the Mallory-Weiss tear. Curr Treat Options Gastroenterol 2003; 6: 75-83.
84. Huang SP, Wang HP, Lee YC i wsp. Endoscopic hemoclip placement and epinephrine injection for Mallory-Weiss syndrome with active bleeding. Gastrointest Endosc 2002; 55: 842-6.
85. Yamaguchi Y, Yamato T, Katsumi N i wsp. Endoscopic hemoclipping for upper GI bleeding due to Mallory-Weiss syndrome. Gastrointest Endosc 2001; 53: 427-30.
86. Machicado GA, Jensen DM, Randall GM. Upper gastrointestinal angiomata - diagnosis and treatment. Gastrointest Clin North Am 1991; 21: 241-62.
87. Sebastian S, O'Morain CA, Buckley MJ. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther 2003; 18: 157-65.
88. Norton ID, Petersen BT, Sorbi D i wsp. Management and long-term prognosis of Dieulafoy lesion. Gastrointest Endosc 1999; 50: 762-7.
89. Schmulewitz N, Baillie J. Dieulafoy lesions: a review of 6 years of experience at a tertiary referral center. Am J Gastroenterol 2001; 96: 1688-94.
90. Parra-Blanco A, Takahashi H, Mendez Jerez PV i wsp. Endoscopic management of Dieulafoy lesions of the stomach: a case study of 26 patients. Endoscopy 1997; 29: 834-9.
91. Cheng CL, Liu NJ, Lee CS i wsp. Endoscopic management of Dieulafoy lesions in acute nonvariceal upper gastrointestinal bleeding. Dig Dis Sci 2004; 49: 1139-44.
92. Sone Y, Kumada T, Toyoda H i wsp. Endoscopic management and follow up of Dieulafoy lesion in the upper gastrointestinal tract. Endoscopy 2005; 37: 449-53.
93. Valera JM, Pino RQ, Poniachik J i wsp. Endoscopic band ligation of bleeding dieulafoy lesions: the best therapeutic strategy. Endoscopy 2006; 38: 193-4.
94. Savides TJ, Jensen DM, Cohen J i wsp. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy 1996; 28: 244-8.
95. Loftus EV, Alexander GL, Ahlquist DA, Balm RK. Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions. Mayo Clin Proc 1994; 69: 736-40.
96. Suzuki H, Miho O, Watanabe Y i wsp. Endoscopic laser therapy in the curative and palliative treatment of upper gastrointestinal cancer. World J Surg 1989; 13: 158-64.
97. Mathus-Vliegen EM, Tytgat GN. Analysis of failures and complications of neodymium: YAG laser photocoagulation in gastrointestinal tract tumors. A retrospective survey of 18 years' experience. Endoscopy 1990; 22: 17-23.
98. Laine L, Cohen H, Brodhead J i wsp. Prospective evaluation of immediate versus delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterology 1992; 102: 314-6.
99. Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978; 74: 38-43.
100. Li Y, Sha W, Nie Y i wsp. Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterol Hepatol 2000; 15: 148-54.
101. Vreeburg EM, Levi M, Rauws EA i wsp. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Pharmacol Ther 2001; 15: 639-46.
102. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia - a post hoc analysis from the Cochrane Collaboration. Aliment Pharmacol Ther 2005; 21: 1055-61.
103. Gisbert JP, Gonzalez L, Calvet X i wsp. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 2001; 15: 917-26.
104. Martin JE, Macaulay SS, Zarnke KB i wsp. Proton pump inhibitors versus H2-antagonists or placebo for upper gastrointestinal bleeding with or without endoscopic hemostasis: a meta-analysis [Abstract]. Gastroenterology 2003; 124 (Suppl 1): A625.
105. Bardou M, Toubouti YM, Benhaberou-Brun D i wsp. High dose intravenous proton pump inhibitors decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding: a series of meta-analyses [Abstract]. Gastroenterology 2003; 124 (Suppl 1): A625.
106. Andriulli A, Annese V, Caruso N i wsp. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of metaanalyses. Am J Gastroenterol 2005; 100: 207-19.
107. Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a metaanalysis. J Gastroenterol Hepatol 2005; 20: 11-25.
108. Bardou M, Toubouti Y, Benhaberou-Brun D i wsp. Metaanalysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005; 21: 677-86.
109. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. Br Med J 2005; 330: 568.
110. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006; 1: CD002094.
111. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay - results from the Cochrane Collaboration. Aliment Pharmacol Ther 2005; 22: 169-74.
112. Barkun A, Sabbah S, Enns R i wsp. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004; 99: 1238-46.
113. Rockey DC. Proton pump inhibitors in acute peptic ulcer bleeding. Gastroenterology 2005; 129: 756-7.
114. Brunner G, Luna P, Hartmann M i wsp. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med 1996; 69: 225-31.
115. Hasselgren G, Keelan M, Kirdeikis P i wsp. Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole. Eur J Gastroenterol Hepatol 1998; 10: 601-6.
116. van Rensburg CJ, Hartmann M, Thorpe A i wsp. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 2003; 98: 2635-41.
117. Lau JY, Chung SC, Leung JW i wsp. The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study. Endoscopy 1998; 30: 513-8.
118. Udd M, Miettinen P, Palmu A i wsp. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol 2001; 36: 1332-8.
119. Cheng HC, Kao AW, Chuang CH, Sheu BS. The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci 2005; 50: 1194-201.
120. Simon-Rudler M, Massard I, Bernard-Chabert B i wsp. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study. Aliment Pharmacol Ther 2007; 25: 949-54.
121. Andriuili A, Loperfido S, Focareta R i wsp. Bolus versus continuous high-dose omeprazole infusion combined with endoscopic hemostasis in peptic ulcer bleeding. a randomized, multicenter, Italian study [Abstract]. Gastrointest Endosc 2007; 65: AB12O.
122. Murthy S, Keyvani L, Leeson S, Targownik LE. Intravenous versus high-dose oral proton pump inhibitor therapy after endoscopic hemostasis of high-risk lesions in patients with acute nonvariceal upper gastrointestinal bleeding. Dig Dis Sci 2007; 52: 1685-90.
123. Lesur G, Bour B, Aegerter P; Association Nationale des Hépatogastroentérologues des Hôpitaux Généraux. Management of bleeding peptic ulcer in France: a national inquiry Gastroenterol Clin Biol 2005; 29: 140-4.
124. Adamsen S, Bendix J, Kallehave F i wsp. Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcer. Scand J Gastroenterol 2007; 42: 318-23.
125. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-22.
126. Mainie I, Wiggins W, Tham T. Use of intravenous pantoprazole for the treatment of acute upper gastrointestinal hemorrhage [Abstract]. Gastrointest Endosc 2003; 57: AB155.
127. Enns R, Andrews C, Fishman M i wsp. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. Can J Gastroenterol 2004; 18: 567-71.
128. Guda NM, Noonan M, Kreiner MJ i wsp. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? Am J Gastroenterol 2004; 99: 1233-7.
129. Mat Saad AZ, Collins N, Lobo MM, O'Connor HJ. Proton pump inhibitors: a survey of prescribing in an Irish general hospital. Int J Clin Pract 2005; 59: 31-4.
130. Leontiadis GI, Howden CW. Pharmacologic treatment of peptic ulcer bleeding. Curr Treat Options Gastroenterol 2007; 10: 134-42.
131. Collins R, Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985; 313: 660-6.
132. Selby NM, Kubba AK, Hawkey CJ. Acid suppression in peptic ulcer haemorrhage: a "meta-analysis". Aliment Pharmacol Ther 2000; 14: 1119-26.
133. Levine JE, Leontiadis GI, Sharma VK, Howden CW. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002; 16: 1137-42.
134. Zed PJ, Loewen PS, Slavik RS, Marra CA Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother 2001; 35: 1528-34.
135. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994; 106: 60-4.
136. Barkun AN, Cockeram AW, Plourde V, Fedorak RN. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999; 13: 1565-84.
137. Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Ann Intern Med 1997; 127: 1062-71.
138. Tsibouris P, Zintzaras E, Lappas C i wsp. High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding. Am J Gastroenterol 2007; 102: 1192-9.
139. Saruc M, Can M, Küçükmetin N i wsp. Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: a pilot study. Med Sci Monit 2003; 9: P184-7.
140. Villanueva C, Balanzo J, Torras X i wsp. Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 1994; 40: 34-9.
141. Saeed ZA, Cole RA, Ramirez FC i wsp. Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial. Endoscopy 1996; 28: 288-94.
142. Messmann H, Schaller P, Andus T i wsp. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy 1998; 30: 583-9.
143. Trap R, Skarbye M, Rosenberg J. Planned second look endoscopy in patients with bleeding duodenal or gastric ulcers. Dan Med Bull 2000; 47: 220-3.
144. Chiu PW, Lam CY, Lee SW i wsp. Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial. Gut 2003; 52: 1403-7.
145. Lau JY, Sung JJ, Lam YH i wsp. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999; 340: 751-6.
146. Guglielmi A, Ruzzenente A, Sandri M i wsp. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 2002; 34: 778-86.
147. Chiu PW, Joeng HK, Choi CL i wsp. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors? Endoscopy 2006; 38: 726-9.
148. Aina R, Oliva VL, Therasse E i wsp. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001; 12: 195-200.
149. Schenker MP, Duszak R Jr, Soulen MC i wsp. Upper gastrointestinal hemorrhage and transcatheter embolotherapy: clinical and technical factors impacting success and survival. J Vasc Interv Radiol 2001; 12: 1263-71.
150. De Wispelaere JF, De Ronde T, Trigaux JP i wsp. Duodenal ulcer hemorrhage treated by embolization: results in 28 patients. Acta Gastroenterol Belg 2002; 65: 6-11.
151. Ripoll C, Bañares R, Beceiro I i wsp. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol 2004; 15: 447-50.
152. Kim SK, Duddalwar V. Failed endoscopic therapy and the interventional radiologist: non-variceal upper gastrointestinal bleeding. Tech Gastrointest Endosc 2005; 7: 148-55.
153. Branicki FJ, Coleman SY, Fok PJ i wsp. Bleeding peptic ulcers: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990; 14: 262-9.
154. Ishikawa M, Kikutsuji T, Miyauchi T, Sakakihara Y. Limitations of endoscopic hemostasis by ethanol injection and surgical management for bleeding peptic ulcer. J Gastroenterol Hepatol 1994; 9: 64-8.
155. Quist P, Arnesen KE, Jacobsen CD, Rosseland AR. Endoscopic treatment and restrictive surgery in the management of peptic ulcer bleeding. Five year experience in a central hospital. J Gastroenterol 1994; 29: 569-76.
156. Park KG, Steele RJ, Mollison J, Crofts TJ. Prediction of recurrent bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal hemorrhage. Br J Surg 1995; 81: 1465-8.
157. Ell C, Hagmüller F, Schmitt W i wsp. Multizentrische prospektive Untersuchung zum aktuellen Stand der Ulkusblutung in Deutschland. Dtsch Med Wochenschr 1995; 120: 3-9.
158. Ohmann C, Imhof M, Röher HD. Trends in peptic ulcer bleeding and surgical treatment. World J Surg 2000; 24: 284-93.
159. Schoenberg MH. Surgical therapy for peptic ulcer and nonvariceal bleeding. Langenbecks Arch Surg 2001; 386: 98-103.
160. Kazanjian KK, Hines OJ. Nonvariceal upper gastrointestinal bleeding: when endoscopic therapy fails - a surgeon's perspective. Tech Gastrointest Endosc 2005; 7: 156-9.
161. Poxon VA, Keighley MR, Dykes PW i wsp. Comparison of minimal and conventional surgery in patients with bleeding peptic ulcer: a multicenter trial. Br J Surg 1991; 78: 1344-5.
162. Millat B, Hay JM, Valleur P i wsp. French Association for Surgical Research: emergency surgical treatment for bleeding duodenal ulcer: oversewing plus vagotomy versus gastric resection, a controlled randomized trial. World J Surg 1993; 17: 568-73.
163. Martin I, O'Rourke N, Bailey I i wsp. Laparoscopic underruning of bleeding duodenal ulceration: a minimalist approach to therapy. Aust N Z J Surg 1998; 68: 213-5.
164. Vakil N, Fennerty MB. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment Pharmacol Ther 2003; 18: 559-68.
165. Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician 2007; 76: 1005-12.
166. Graham DY, Hepps KS, Ramirez FC i wsp. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-42.
167. Rokkas T, Karamenis A, Mavrogeorgis A i wsp. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
168. Jaspersen D, Koerner T, Schorr W i wsp. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 5-7.
169. Sharma VK, Sahai AV, Corder FA, Howden CW. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther 2001; 15: 1939-47.
170. Gisbert JP, Khorrami S, Carballo F i wsp. H. pylori eradication therapy vs. antisecretory noneradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev 2004; 2: CD004062.
171. Gisbert JP, Calvet X, Feu F i wsp. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Helicobacter 2007; 12: 279-86.
172. Pohl H, Finlayson SR, Sonnenberg A, Robertson DJ. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment? Aliment Pharmacol Ther 2005; 22: 529-37.
173. Lai KC, Hui WM, Lam SK. Bleeding ulcers have high false negative rates for antral Helicobacter pylori when tested with urease test [Abstract]. Gastroenterology 1996; 110: A167.
174. Laine L, Cohen H. Helicobacter pylori: drowning in a pool of blood? Gastrointest Endosc 1999; 49: 398-402.
175. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 848-63.
176. Scheiman JM, Fendrick AM. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Arthritis Res Thor 2005; 7 (Suppl 4): S23-9.
177. Scheiman JM, Fendrick AM. Summing the risk of NSAID therapy. Lancet 2007; 369: 1580-1.
178. Chan FK, Wong VW, Suen BY i wsp. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007; 369: 1621-6.